載入...
RAS-MAPK in ALK targeted therapy resistance
The clinical success of ALK targeted therapy is limited by resistance. To identify rational co-targeting strategies to enhance clinical outcomes, we explored the molecular basis of ALK oncogene dependence in ALK gene rearrangement positive (ALK+) lung adenocarcinoma. We discovered that the RAS-RAF-M...
Na minha lista:
| 發表在: | Cell Cycle |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825705/ https://ncbi.nlm.nih.gov/pubmed/26654768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2015.1096103 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|